Nothing Special   »   [go: up one dir, main page]

Hyde, 2009 - Google Patents

Feminist approaches to social policy

Hyde, 2009

Document ID
12631161129899898221
Author
Hyde C
Publication year
Publication venue
The handbook of social policy

External Links

Snippet

Sage Reference - The Handbook of Social Policy - Feminist Approaches to Social Policy Skip to main content About Browse Reference Select discipline: Select subject: Select topic: Go Information For Free Trial Sign in: Sign in to my profile Get access off-campus Sign in Sign in …
Continue reading at sk.sagepub.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds

Similar Documents

Publication Publication Date Title
Midgley et al. The social development perspective in social policy
BR112013015855A2 (en) compound, use of a compound, methods of prevention, treatment, amelioration or prophylaxis of physiological disorders or diseases, and treatment or amelioration of cosmetic indications; and, pharmaceutical composition.
MX2013004307A (en) Arylamide derivatives as ttx-s blockers.
CL2013001295A1 (en) Compounds derived from 2,3-dihydromidazo (1,2-c) quinazoline substituted with amino alcohols; intermediate compound and its use; pharmaceutical composition; pharmaceutical combination; and its use to treat hyperproliferative disorders and diseases associated with angiogenesis.
WO2012142511A3 (en) Orthomolecular compositions and their use in stabilizing the extracellular matrix
GT201200313A (en) 5-FLUORO-1H-REPLACED PIRAZOLOPIRIDINES AND ITS USE
CU20090148A7 (en) 4-ARIL-1,4-DIHIDRO-1,6-NAFTIRIDINAMIDES REPLACED AND ITS USE
EA201290964A1 (en) Peptide Conjugates of GLP-1 Receptor Agonists and Their Use
IT1404931B1 (en) OPHTHALMIC COMPOSITIONS FOR THE ADMINISTRATION OF LIPO-SOLUBLE ACTIVE PRINCIPLES.
ITMI20091618A1 (en) COMPOSITE PIECE, AS WELL AS THE USE OF THE COMPOSITE PIECE
CL2014000395A1 (en) Compounds derived from substituted pyridazinone; intermediate compound; pharmaceutical composition; pharmaceutical combination; and use in the treatment of schizophrenia, schizoaffective disorder, cognitive disorders or pain.
PE20142432A1 (en) THERAPEUTIC USES OF PROTEINS FROM THE FIBROBLAST GROWTH FACTOR 21
WO2012106665A3 (en) Disialyllacto-n-tetraose (dslnt) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease
BRPI1008108A2 (en) "water redispersible crosslinkable polymer powder composition".
ZA201401678B (en) Novel distributed 3,4-diamino-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
EA201400623A1 (en) NEW 2H-INDASOLS AS ANTAGONISTS EP EPCEPTOR
BR112013015877A2 (en) compound, use of a compound, prevention methods. treatment, amelioration or prophylaxis of physiological disorders or diseases, and treatment or amelioration of cosmetic indications, and, pharmaceutical composition.
Midgley The definition of social policy
Hyde Feminist approaches to social policy
IT1398378B1 (en) CYTICOLINE FOR THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION.
CL2013001445A1 (en) Compounds derived from diphenylamine; Pharmaceutical composition and use in the treatment of inflammatory diseases, such as cancer.
SA515360377B1 (en) Somatostatin-dopamine chimeric analogs
WO2011091410A8 (en) Trpv4 antagonists
EA201101126A1 (en) PHARMACEUTICAL COMPOSITION AND METHOD OF INCREASING HAIR GROWTH
GB201020119D0 (en) Pharamaceutical and other compositions, e.g. for the skin, comprising emulsifying ointment and water